SCHEMBL2730240

SCHEMBL2730240

NC(=O)c1nc2cccc(-c3ccccc3)n2n1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 1/20 0.62
▸ JAK1 P23458 2/20 0.51
▸ JAK2 O60674 3/20 0.49
▸ EGLN2 Q96KS0 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ NTRK1 P04629 1/20 0.44
▸ PIM1 P11309 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ FYN P06241 1/20 0.43
▸ MAP2K1 Q02750 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ DYRK1B Q9Y463 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ MAP3K5 Q99683 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PARP1 P09874 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29079138 0.87 NUDT1 (0.61) NUDT1JAK1JAK2EGLN2KDM4E
SCHEMBL18154780 0.83 JAK1 (0.44) NUDT1JAK1JAK2EGLN2
SCHEMBL19659253 0.80 EGLN2 (0.50) NUDT1JAK1JAK2EGLN2PARP1
SCHEMBL19658699 0.79 GRM2 (0.44) NUDT1JAK1PIM1FYN
SCHEMBL19658700 0.79 NUDT1 (0.38) NUDT1JAK1JAK2EGLN2PIM1
SCHEMBL28485655 0.78 AHR (0.47) NUDT1KDM4EALDH1A1MAPK1HSD17B10
SCHEMBL22439076 0.78 KDM4E (0.43) NUDT1KDM4EALDH1A1MAPK1HSD17B10
SCHEMBL19658973 0.77 L3MBTL1 (0.36) NUDT1JAK2KDM4EALDH1A1MAPK1
SCHEMBL2144054 0.77 NUDT1 (1.00) NUDT1JAK1JAK2EGLN2KDM4E
SCHEMBL21797154 0.76 JAK2 (0.63) JAK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462650-A Non-goetide method for synthesizing nylon 沈阳药科大学 2025-02-18 — — CN disclosed
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 — — EP disclosed
WO-2017004500-A9 BICYCLIC LACTAMS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2017-11-30 — — WO disclosed
EP-3178819-A1 5-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL CARBOXAMIDES AS JAK INHIBITORS Galapagos NV (BE) 2017-06-14 — — EP disclosed
EP-2445911-B1 5-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL CARBOXAMIDES AS JAK INHIBITORS GALAPAGOS NV (BE) 2017-03-01 — — EP disclosed
CN-102482273-B 5-phenyl- [1,2,4] triazolo [1,5-a ] pyridine-2-carboxamides as JAK inhibitors GALAPAGOS NV 2014-09-17 — — CN disclosed
CN-102482273-A 5-phenyl- [1,2,4] triazolo [1,5-a ] pyridine-2-carboxamides as JAK inhibitors GALAPAGOS NV 2012-05-30 — — CN disclosed
EP-2445911-A1 5-PHENYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-2-YL CARBOXAMIDES AS JAK INHIBITORS Galapagos N.V. (BE) 2012-05-02 — — EP disclosed
WO-2010149769-A1 5-PHENYL-[1,2,4 ]TRIAZOLO[1,5-A]PYRIDIN-2-YL CARBOXAMIDES AS JAK INHIBITORS GALAPAGOS NV (BE) 2010-12-29 — — WO disclosed
Send feedback